Western Digital Corp vs GeneDx Holdings Corp — how do they compare? Western Digital Corp trades at $393.93 (market cap $147.23B), while GeneDx Holdings Corp trades at $67.75 (market cap $2.02B). The key difference: Western Digital Corp is far larger — about 72.9× GeneDx Holdings Corp's market cap, and Western Digital Corp pays a 0.15% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Western Digital Corp for 37 Days and GeneDx Holdings Corp for 19 Days on average.
| WDC | WGS | |
|---|---|---|
Market Cap | $147.23B | $2.02B |
Volume | 9,341,468 | 734,640 |
Sector | Technology | Health |
52-Week High | $746.23 | $167.51 |
52-Week Low | $113.13 | $34.51 |
Typical Hold Time | 37 Days | 19 Days |
Enterprise Value | $146.70B | $2.05B |
Dividend Yield | 0.15% | — |
Signals from Pluang's Aura AI — not financial advice
Western Digital (WDC) trades at $394.13, down 2.73% amid concerns about increased competition from Toshiba's planned HDD production expansion. The stock shows strong fundamentals with three consecutive earnings beats and robust profitability metrics including 71.97% net margin and 131.02% ROE. Technical indicators are bearish with the price testing key support at $387, while analyst consensus remains strongly bullish with a $647.58 price target representing 64% upside potential.
Despite near-term competitive pressures, WDC's dominant market position in AI storage and improving financial performance support long-term growth prospects. Key risks include pricing pressure from increased industry capacity and execution challenges in maintaining cost-per-terabyte reductions. The current valuation at 14.61 P/E appears attractive relative to growth expectations.
GeneDx (WGS) trades at $68.50, down 0.04% with a bearish technical signal despite bullish oscillators showing oversold conditions. The company reported mixed Q2 2026 results with revenue of $114.4M beating expectations but net income margin remains negative at -23.4%. Recent developments include new product launches and positive analyst coverage with 91% buy ratings.
While analyst consensus targets $81.00 (18% upside), fundamental challenges persist with negative profitability metrics and high valuation multiples. The stock faces execution risks amid competitive genomics landscape, but operational improvements and testing volume growth provide potential catalysts for recovery.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Western Digital is a vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.
Read more on WDC →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →